ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

KYTX Kyverna Therapeutics Inc

7.37
-0.37 (-4.78%)
Last Updated: 16:11:49
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)
Total Assets 75.2M389.98M
Total Current Assets 60.66M375.49M
Cash and Equivalents 34.65M224.29M
Total Non-Current Assets 15.07M15.66M
Total Liabilities 26.02M28.99M
Total Current Liabilities 19.86M21.87M
Total Non-Current Liabilities 7.08M7.8M
Common Equity 00
Retained Earnings -136.04M-162.74M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Assets 85.49M66.92M75.2M
Total Current Assets 77.09M53.25M60.66M
Cash and Equivalents 76.07M37.74M34.65M
Total Non-Current Assets -46.25M-74M-131.4M
Total Liabilities 23.02M20.25M26.02M
Total Current Liabilities 15.93M11.95M19.86M
Total Non-Current Liabilities 7.11M9.37M7.08M
Total Equity -46.25M-74M-131.4M
Common Equity 000
Retained Earnings -46.78M-75.68M-136.04M